In Q2 fiscal 2026 (the quarter ended July 4, 2026), Waters's largest business segment was Waters Analytical and Materials Sciences, with $756.00 million or 46% of revenue, up 6.6% from a year earlier. Next: Waters Advanced Diagnostics (32%) and Waters Biosciences (22%).
By product or service, Consumables brought in 47%, Instrument Systems brought in 28% and Service brought in 26% of revenue in Q2 fiscal 2026.
By region, United States brought in 35%, European Union brought in 31% and Asia Other brought in 15% of revenue in Q2 fiscal 2026.
The fastest-growing business segment from a year earlier was Waters Advanced Diagnostics (+740.3%).
From company filings, in USD; latest quarter ended July 4, 2026; quarterly data from Q3 fiscal 2017.

Fiscal quarters, from company filings
| Business segment | Q2 FY26 | Q1 FY26 | Q2 FY25 | Q1 FY25 | Share |
|---|---|---|---|---|---|
| Waters Analytical and Materials Sciences | $756.0M | $686.0M | $709.0M | $609.0M | 46% |
| Waters Advanced Diagnostics | $521.0M | $349.0M | $62.0M | $53.0M | 32% |
| Waters Biosciences | $368.0M | $232.0M | – | – | 22% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
| Product or service | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| Consumables | $765.0M | $543.0M | – | $165.0M | 47% |
| Instrument Systems | $455.0M | $376.0M | – | $308.0M | 28% |
| Service | $425.0M | $348.0M | – | $298.0M | 26% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
| Region | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| United States | $570.0M | $415.0M | $245.3M | $229.0M | 35% |
| European Union | $505.0M | $412.0M | – | $225.0M | 31% |
| Asia Other | $244.0M | $197.0M | $156.2M | $149.0M | 15% |
| China | $206.0M | $153.0M | $113.5M | $117.0M | 13% |
| Americas Other | $120.0M | $90.0M | $47.6M | $51.0M | 7% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
Waters Analytical and Materials Sciences, Waters Advanced Diagnostics and Waters Biosciences (as reported for Q2 fiscal 2026).
Waters Analytical and Materials Sciences: $756.00 million, or 46% of revenue, in Q2 fiscal 2026.
By revenue in Q2 fiscal 2026: Consumables (47%), Instrument Systems (28%) and Service (26%).
By region in Q2 fiscal 2026: United States (35%), European Union (31%), Asia Other (15%) and China (13%).
Click a bar to see that period below. Striped bars are calculated fourth quarters; an empty slot means it could not be calculated on the same basis i
Fiscal quarter ended Jul 4, 2026
| Item | Revenue | Share |
|---|---|---|
| Waters Analytical and Materials Sciences | USD 756.00M | 46.0% |
| Waters Advanced Diagnostics | USD 521.00M | 31.7% |
| Waters Biosciences | USD 368.00M | 22.4% |
Sum of items USD 1.65B. Shares are of the items shown. Click an item with › to see its parts.
Every item and period in one grid. Purple = calculated; "–" = not available.
| Item | Q2 FY26 | Q1 FY26 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|
| Waters Analytical and Materials Sciences | 756.0M | 686.0M | 709.0M | 609.0M |
| Waters Advanced Diagnostics | 521.0M | 349.0M | 62.0M | 53.0M |
| Waters Biosciences | 368.0M | 232.0M | – | – |